The Enterprise Value as of November 2024 (TTM) for Luye Pharma Group Ltd. (LYPHF) is 15.48B

According to Luye Pharma Group Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 15.48B. This represents a change of -3.11% compared to the average of 15.98B of the last 4 quarters.

Luye Pharma Group Ltd. (LYPHF) Historical Enterprise Value (quarterly & annually)

How has LYPHF Enterprise Value performed in the past?

The mean historical Enterprise Value of Luye Pharma Group Ltd. over the last ten years is 19.57B. The current 15.48B Enterprise Value has changed 7.81% with respect to the historical average. Over the past ten years (40 quarters), LYPHF's Enterprise Value was at its highest in in the September 2022 quarter at 25.35B. The Enterprise Value was at its lowest in in the December 2023 quarter at 14.20B.

Luye Pharma Group Ltd. (LYPHF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Luye Pharma Group Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Luye Pharma Group Ltd. (LYPHF) Average Enterprise Value

How has LYPHF Enterprise Value performed in the past?

The current Enterprise Value of Luye Pharma Group Ltd. (LYPHF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Luye Pharma Group Ltd. (LYPHF) Enterprise Value vs. Peers

How is LYPHF’s Enterprise Value compared to its peers?

Luye Pharma Group Ltd.’s Enterprise Value is less than Astellas Pharma Inc. (3.48T), less than Sanofi (133.10B), greater than Amarin Corporation plc (76.89M), less than Novartis AG (222.57B), greater than Scilex Holding Company (199.99M), less than Biogen Inc. (27.96B), less than Gilead Sciences, Inc. (135.65B), less than AstraZeneca PLC (230.26B), less than Johnson & Johnson (389.36B), less than Bristol-Myers Squibb Company (162.91B), less than AbbVie Inc. (376.52B), less than Eli Lilly and Company (737.85B), less than Pfizer Inc. (210.88B), less than Merck & Co., Inc. (274.43B),

Build a custom stock screener for Luye Pharma Group Ltd. (LYPHF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Luye Pharma Group Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Luye Pharma Group Ltd. (LYPHF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Luye Pharma Group Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.